Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (151-160 of 332) with videos related to

Pageof 34
Sort By:
World Journal of Urology|February 26, 2021
Outcome after resection of occult and non-occult lymph node metastases at the time of nephrectomyTeele Kuusk, Tobias Klatte, Patricia Zondervan, et al.
BMC Medicine|November 16, 2016
Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinomaShanthini M Crusz, Yen Zhi Tang, Shah-Jalal Sarker, et al.
Nature Reviews. Urology|June 21, 2024
Renal mass biopsy - a practical and clinicopathologically relevant approach to diagnosisHussein Mansour, My-Anh Tran-Dang, Miles Walkden, et al.
Urology|April 8, 2023
Epitheloid Angiomyolipomas of the Kidney: Rare Renal Tumors Associated With Poor PrognosesJulian Aquilina, Joana B Neves, Soha El-Sheikh, et al.
World Journal of Urology|September 21, 2020
Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumorJoost M Blok, Henk G van der Poel, J Martijn Kerst, et al.
BJU International|June 25, 2009
Prostate-sparing cystectomy: long-term oncological resultsRemco R de Vries, Jakko A Nieuwenhuijzen, Harm van Tinteren, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic ProgressionNikolaos Grivas, Esther Wit, Floris Pos, et al.
European Urology|May 21, 2014
A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancerLaurence Albiges, Toni Choueiri, Bernard Escudier, et al.
European Urology Open Science|January 5, 2023
Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence GroupsLorenzo Marconi, Teele Kuusk, Umberto Capitanio, et al.
European Urology|November 6, 2016
Cytoreductive Nephrectomy in the Tyrosine Kinase Inhibitor Era: A Question That May Never Be AnsweredGrant D Stewart, Michael Aitchison, Axel Bex, et al.
Pageof 34

Showing results (151-160 of 332) with videos related to

Sort By:
Pageof 34
World Journal of Urology|February 26, 2021
Outcome after resection of occult and non-occult lymph node metastases at the time of nephrectomyTeele Kuusk, Tobias Klatte, Patricia Zondervan, et al.
BMC Medicine|November 16, 2016
Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinomaShanthini M Crusz, Yen Zhi Tang, Shah-Jalal Sarker, et al.
Nature Reviews. Urology|June 21, 2024
Renal mass biopsy - a practical and clinicopathologically relevant approach to diagnosisHussein Mansour, My-Anh Tran-Dang, Miles Walkden, et al.
Urology|April 8, 2023
Epitheloid Angiomyolipomas of the Kidney: Rare Renal Tumors Associated With Poor PrognosesJulian Aquilina, Joana B Neves, Soha El-Sheikh, et al.
World Journal of Urology|September 21, 2020
Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumorJoost M Blok, Henk G van der Poel, J Martijn Kerst, et al.
BJU International|June 25, 2009
Prostate-sparing cystectomy: long-term oncological resultsRemco R de Vries, Jakko A Nieuwenhuijzen, Harm van Tinteren, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic ProgressionNikolaos Grivas, Esther Wit, Floris Pos, et al.
European Urology|May 21, 2014
A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancerLaurence Albiges, Toni Choueiri, Bernard Escudier, et al.
European Urology Open Science|January 5, 2023
Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence GroupsLorenzo Marconi, Teele Kuusk, Umberto Capitanio, et al.
European Urology|November 6, 2016
Cytoreductive Nephrectomy in the Tyrosine Kinase Inhibitor Era: A Question That May Never Be AnsweredGrant D Stewart, Michael Aitchison, Axel Bex, et al.
Pageof 34